Health Care • Hospital/Nursing Management
$135.90 ▲ +4.41
(+3.35%)
MKT CAP: $12.97B • VOL: 1.80M
52W L $93 52W H $137
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$114
MEDIAN
$152
MEAN
$155
HIGH
$185
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE EHC TAPE
EHC // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $164.44 | $156.28 | 2025-02-14 | $123.67 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $171.23 | $160.36 | 2025-02-06 | $127.75 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $154.93 | $149.49 | 2025-01-29 | $130.46 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $138.62 | — | 2025-01-17 | $133.18 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $119.59 | $129.10 | 2025-01-09 | $120.95 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $161.72 | $141.34 | 2024-12-18 | $118.23 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $131.82 | $137.26 | 2024-12-04 | $126.39 | -4.3% | 48% | C |